Carregant...
Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
The novel coronavirus, SARS-coronavirus (CoV)-2 (SARS-CoV-2), has caused over 17 million infections in just a few months, with disease manifestations ranging from largely asymptomatic infection to critically severe disease. The remarkable spread and unpredictable disease outcomes continue to challen...
Guardat en:
| Publicat a: | mSphere |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7471005/ https://ncbi.nlm.nih.gov/pubmed/32878931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mSphere.00622-20 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|